Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 18, 2018

DrugPatentWatch Database Preview

Cipla Company Profile

« Back to Dashboard

What is the competitive landscape for CIPLA, and what generic and branded alternatives to CIPLA drugs are available?

CIPLA has sixty-one approved drugs.

There are thirty-two tentative approvals on CIPLA drugs.

Summary for Cipla

US Patents:	0
Tradenames:	53
Ingredients:	53
NDAs:	61
Patent Litigation for Cipla:	See patent lawsuits for Cipla
PTAB Cases with Cipla as petitioner:	See PTAB cases with Cipla as petitioner

Drugs and US Patents for Cipla

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cipla Ltd	ABACAVIR SULFATE AND LAMIVUDINE	abacavir sulfate; lamivudine	TABLET;ORAL	091144-001	Mar 28, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Cipla Ltd	DECITABINE	decitabine	INJECTABLE;INTRAVENOUS	208601-001	Nov 16, 2017	AP	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Cipla Ltd	ZIDOVUDINE	zidovudine	SYRUP;ORAL	077981-001	Jun 26, 2008	AA	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Cipla Ltd	PIOGLITAZONE HYDROCHLORIDE	pioglitazone hydrochloride	TABLET;ORAL	076798-001	Oct 26, 2012	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys

Chubb

Argus Health

Federal Trade Commission

Express Scripts

Johnson and Johnson

Julphar

Cantor Fitzgerald

Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.